This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on February 14, 2022 and assigned serial number 91274513 by the TTAB.

Plaintiff:
Horizon Pharma USA Inc., Horizon Therapeutics Ireland DAC represented by FRANCES M. JAGLA of CHRISTENSEN O’CONNOR JOHNSON KINDNESS.
Trademark Information: HORIZON – US Trademark Serial Number 88324922
View Trademark Status at USPTO
View Trademark Documents at USPTO

Defendant:
Natera, Inc. represented by TRICIA L. SCHULZ of FOLEY & LARDNER LLP.
Trademark Information: HORIZON – US Trademark Serial Number 88299910
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
February 14, 2022 – FILED AND FEE
February 14, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
February 14, 2022 – INSTITUTED
March 21, 2022 – D MOT FOR EXT W/ CONSENT
March 21, 2022 – EXTENSION OF TIME GRANTED
May 11, 2022 – D MOT FOR EXT W/ CONSENT
May 11, 2022 – EXTENSION OF TIME GRANTED
August 18, 2022 – D MOT FOR EXT W/ CONSENT
August 18, 2022 – EXTENSION OF TIME GRANTED
October 21, 2022 – D MOT FOR EXT W/ CONSENT
October 21, 2022 – EXTENSION OF TIME GRANTED
December 16, 2022 – D MOT FOR EXT W/ CONSENT
December 16, 2022 – EXTENSION OF TIME GRANTED
February 16, 2023 – P MOT FOR EXT W/ CONSENT
February 17, 2023 – EXTENSION OF TIME GRANTED
March 16, 2023 – MOT TO AMEND APPLICATION
March 29, 2023 – BD DECISION: OPP DISMISSED W/ PREJ
March 29, 2023 – TERMINATED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.